Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10248
Title: Evidence-based medicine: classifying the evidence from clinical trials--the need to consider other dimensions.
Authors: Bellomo, Rinaldo;Bagshaw, Sean M
Affiliation: Department of Intensive Care, Austin Hospital, Studley Rd, Heidelberg, Victoria 3084, Australia
rinaldo.bellomo@austin.org.au
Issue Date: 2006
Citation: Critical Care (london, England); 10(5): 232
Abstract: The current approach to assessing the quality of evidence obtained from clinical trials focuses on three dimensions: the quality of the design (with double-blinded randomised controlled trials representing the highest level of such design); the statistical power (beta) and the level of significance (alpha). While these aspects are important, we argue that other significant aspects of trial quality impinge upon the truthfulness of the findings: biological plausibility, reproducibility and generalisability. We present several recent studies in critical care medicine where the design, beta and alpha components of the study are seemingly satisfactory but where the aspects of biological plausibility, reproducibility and generalisability show serious limitations. Accordingly, we argue for more reflection, definition and consensus on these aspects of the evaluation of evidence.
Internal ID Number: 17029653
URI: http://ahro.austin.org.au/austinjspui/handle/1/10248
DOI: 10.1186/cc5045
URL: http://www.ncbi.nlm.nih.gov/pubmed/17029653
Type: Journal Article
Subjects: Evidence-Based Medicine.classification.methods
Humans
Randomized Controlled Trials as Topic.classification.methods
Appears in Collections:Journal articles

Files in This Item:
File Description SizeFormat 
17029653.pdf68.96 kBAdobe PDFThumbnail
View/Open


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.